Company that owns the tech behind Oxford/AstraZeneca Covid vaccine raises $111m
Home/FT/Vaccitech valued at $579m in US public offering FT Vaccitech valued at $579m in US public offering Financial Times0 Less than a minute Facebook X LinkedIn Company that owns the tech behind Oxford/AstraZeneca Covid vaccine raises $111m Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to email a link to a friend (Opens in new window) Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
